Want to see TSE:MLCO full AI Analyst Report?
Mountain Valley MD (MLCO) AI Stock Analysis
Mountain Valley MD
(CNQX:MLCO)
The score is primarily constrained by weak financial performance—very small revenue, large ongoing losses, and significant negative operating/free cash flow. Technical indicators also lean bearish with the price below key moving averages and a negative MACD, while valuation provides limited support due to a negative P/E and no dividend yield.
Mountain Valley MD (MLCO) vs. iShares MSCI Canada ETF (EWC)
- Market Cap
- CAD 22.85M
- Dividend Yield
- ―
- Average Volume (3M)
- 155.35K
- Price to Earnings (P/E)
- -5.2
- Beta (1Y)
- -0.70
- Revenue Growth
- 48.94%
- EPS Growth
- 53.81%
- Country
- Canada
- Employees
- 1
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Biotechnology
Mountain Valley MD Business Overview & Revenue Model
Company Description
The More Life Co. Corp. is a biotechnology company, which engages in the provision of solutions to optimize human, animal, and plant health. Its patented technologies includes Quicksomeâ„¢ and Quicksolâ„¢. The Quicksomeâ„¢ patented technology utilizes prop...
Mountain Valley MD Financial Statement Overview
Summary
Overall fundamentals are weak: revenue is very small ($70K TTM) with modest growth, but operating and net losses are extremely large relative to revenue and free cash flow remains deeply negative (ongoing cash burn). Low reported debt helps, but equity volatility and continued financing dependence materially increase risk.
Income Statement
18Very NegativeBalance Sheet
38NegativeCash Flow
16Very Negative| Breakdown | TTM | Jun 2026 | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 65.00K | 65.00K | 49.00K | 60.00K | 0 | 110.00K |
| Gross Profit | 37.00K | -2,000 | 49.00K | -346.00K | -446.00K | 70.00K |
| EBITDA | -2.26M | -2.27M | -3.16M | -2.78M | -6.89M | -9.29M |
| Net Income | -2.79M | -2.79M | -7.47M | -7.67M | -7.44M | -9.71M |
Balance Sheet | ||||||
| Total Assets | 524.00K | 524.00K | 2.74M | 8.97M | 16.77M | 25.27M |
| Cash, Cash Equivalents and Short-Term Investments | 334.00K | 334.00K | 1.72M | 5.92M | 9.71M | 14.22M |
| Total Debt | 403.00K | 403.00K | 0 | 0 | 6,000 | 44.00K |
| Total Liabilities | 665.00K | 665.00K | 209.00K | 258.00K | 591.00K | 422.00K |
| Stockholders Equity | -141.00K | -141.00K | 2.53M | 8.71M | 16.18M | 24.85M |
Cash Flow | ||||||
| Free Cash Flow | -2.12M | -2.12M | -3.91M | -3.80M | -4.85M | -5.68M |
| Operating Cash Flow | -2.11M | -2.11M | -3.90M | -3.30M | -4.79M | -5.59M |
| Investing Cash Flow | 200.00K | 200.00K | -290.00K | -503.00K | 1.89M | -98.00K |
| Financing Cash Flow | 519.00K | 519.00K | 0 | -6,000 | -1.60M | 395.00K |
Mountain Valley MD Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:MLCO, the sentiment is Negative. The current price of 0.04 is below the 20-day moving average (MA) of 0.05, below the 50-day MA of 0.06, and below the 200-day MA of 0.06, indicating a bearish trend. The MACD of -0.00 indicates Positive momentum. The RSI at 45.07 is Neutral, neither overbought nor oversold. The STOCH value of 75.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:MLCO.
Mountain Valley MD Peers Comparison
Overall Rating
TSE:LOBE43Neutral
TSE:PCLO42Neutral
TSE:RVV42Neutral- TSE:MLCO41Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| TSE:LOBE | 43Neutral | CAD 13.87M | -2.18 | -338.76% | ― | ― | 31.00% |
| TSE:PCLO | 42Neutral | CAD 9.34M | -2.67 | 28.59% | ― | 0.90% | 57.73% |
| TSE:RVV | 42Neutral | CAD 8.37M | -0.83 | 26.78% | ― | ― | 90.84% |
| TSE:MLCO | 41Neutral | CAD 22.85M | -5.15 | -443.11% | ― | 48.94% | 53.81% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TSE:MLCO | Mountain Valley Md Holdings Inc | 0.05 | 0.04 | 233.33% | |
| TSE:RVV | Revive Therapeutics | 0.02 | 0.01 | 100.00% | |
| TSE:PCLO | Pharmacielo | 0.05 | 0.01 | 11.11% | |
| TSE:LOBE | Lobe Sciences Ltd | 0.04 | 0.00 | 0.00% |
Mountain Valley MD Corporate Events
More Life Company’s Quicksome Study Shows Rapid Sublingual Testosterone Delivery
PositiveThe More Life Company reported results from an exploratory human pharmacokinetic study of its Quicksome sublingual delivery technology using USP-grade testosterone. In an eight-participant trial, 5 mg and 15 mg Quicksome tablets produced substantial...
The More Life Company Moves to U.S. Commercialization for Quicksome Compounded Drugs
PositiveThe More Life Company Corp. has signed a strategic letter of intent with an established U.S. 503A compounding pharmacy to develop, compound and commercialize Quicksome™-enabled prescription compounded pharmaceuticals in the United States. The c...
The More Life Company Updates U.S. and Canadian Trading Symbols After Rebrand
PositiveThe More Life Company Corp., formerly Mountain Valley MD Holdings Inc., operates in the life sciences sector with a focus on technologies that enhance crop productivity and resilience and improve the formulation, stability and delivery of active ingr...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 23, 2026